Stay updated on Lecanemab Safety, Tolerability & Efficacy in Early Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Lecanemab Safety, Tolerability & Efficacy in Early Alzheimer's Clinical Trial page.

Latest updates to the Lecanemab Safety, Tolerability & Efficacy in Early Alzheimer's Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2 with no substantive content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedA new revision tag v3.4.1 was added and the previous v3.4.0 tag removed. No visible changes to core study content or functionality.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision: v3.3.4 has been added, replacing Revision: v3.3.3.SummaryDifference0.0%

- Check62 days agoChange DetectedExpanded the study locations to include numerous sites across the United States, Canada, and Europe (e.g., Alabama, Arizona, California; Ontario, Quebec; Paris; Berlin; etc.). It clarifies where recruitment and participation are possible.SummaryDifference2%

- Check70 days agoChange DetectedResults Submitted has been added and No Results Posted has been removed. This indicates that the study's results have been submitted for public listing.SummaryDifference0.0%

- Check91 days agoChange DetectedPublications section now notes that entries are automatically filled from PubMed and may not all pertain to the study, and the revision label changes from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Lecanemab Safety, Tolerability & Efficacy in Early Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lecanemab Safety, Tolerability & Efficacy in Early Alzheimer's Clinical Trial page.